Klinische Erfahrungen mit dem implantierbaren atrialen Defibrillator (Atrioverter) bei Patienten mit Vorhofflimmern

@article{Seidl1999KlinischeEM,
  title={Klinische Erfahrungen mit dem implantierbaren atrialen Defibrillator (Atrioverter) bei Patienten mit Vorhofflimmern},
  author={Karlheinz Seidl and Werner Jung and Harald Schwacke and Ch. Wolpert and Axel Dr{\"o}gem{\"u}ller and Susanne Spehl and Brigitte M Schumacher and Bahman Esmailzadeh and Christiane Werling and Jochen Senges},
  journal={Zeitschrift f{\"u}r Kardiologie},
  year={1999},
  volume={88},
  pages={574-581}
}
Due to the limited efficacy of drug therapy in atrial fibrillation and the high rate of recurrence, strong efforts were made to find non-pharmacological strategies. For three years now, the implantable atrial defibrillator Metrix™ from InControl has been available as an alternative therapy. From October 1995 to the present the atrial defibrillator was implanted in 179 patients worldwide. The sensitivity of the system and its algorithms to detect atrial fibrillation is 90%; the specifity to… CONTINUE READING